Literature DB >> 8388398

Antigenic and genetic differentiation of the two putative types of human herpes virus 6.

J T Aubin1, H Agut, H Collandre, K Yamanishi, B Chandran, L Montagnier, J M Huraux.   

Abstract

Ten human herpes virus 6 (HHV-6) strains from different origins were studied using reactivity to monoclonal antibodies and polymerase chain reaction analysis. Using immunofluorescence and neutralization assays, two monoclonal antibodies gave a positive reaction with the ten strains while three others only reacted with a fraction of these strains. This differential reactivity permitted segregation of the ten strains into two non-overlapping antigenic groups, designated as I and II. DNA was amplified from two regions of HHV-6 genome corresponding to the putative large tegument protein (LTP) gene and major capsid protein (MCP) gene, respectively. The restriction analysis of amplified products using HindIII for LTP and HaeII for MCP showed identical patterns among the strains belonging to the same antigenic group while BglII, TaqI and ClaI provided distinct patterns among group II strains. The nucleotide sequence of amplified products was determined and homology was found to be equal to or greater than 99% within each group whereas it was 96% between both groups. The number of amino-acid changes was higher when comparing two strains of different groups than when comparing two strains of the same group. The converging results of antigenic and genetic analyses led us to consider HHV-6 groups I and II as two distinct types of HHV-6 species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388398     DOI: 10.1016/0166-0934(93)90129-f

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  18 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection.

Authors:  J Rohayem; J Dinger; R Fischer; K Klingel; R Kandolf; A Rethwilm
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Alphaherpesvirus origin-binding protein homolog encoded by human herpesvirus 6B, a betaherpesvirus, binds to nucleotide sequences that are similar to ori regions of alphaherpesviruses.

Authors:  N Inoue; T R Dambaugh; J C Rapp; P E Pellett
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Human herpesvirus-6 strain groups: a nomenclature.

Authors: 
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Identification of a lytic-phase origin of DNA replication in human herpesvirus 6B strain Z29.

Authors:  S Dewhurst; S C Dollard; P E Pellett; T R Dambaugh
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Variation of DNA sequence in immediate-early gene of human herpesvirus 6 and variant identification by PCR.

Authors:  T Yamamoto; T Mukai; K Kondo; K Yamanishi
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

7.  Human herpesvirus 6 open reading frame U83 encodes a functional chemokine.

Authors:  P Zou; Y Isegawa; K Nakano; M Haque; Y Horiguchi; K Yamanishi
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Coinfection with human herpesvirus 6 variants A and B in lung tissue.

Authors:  R W Cone; M L Huang; R C Hackman; L Corey
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor.

Authors:  Y Isegawa; Z Ping; K Nakano; N Sugimoto; K Yamanishi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 10.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.